Prostate and Urologic Cancer

The Prostate and Urologic Cancer Research Group conducts and supports research on the prevention and early detection of prostate and bladder cancer. Clinical trials and the evaluation of new agents, surrogate biomarkers, and new technologies to identify premalignant lesions are developed and supported.

Read more About the Prostate and Urologic Cancer Research Group.

Staff

Funding Opportunities

Grants

Clinical Trials

Publications

Cancer Prevention Clinical Trials Network (CP-CTNet)

Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.

Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)

Major medical research centers conduct systematic early clinical development of promising preventive agents.

News and Events

Part 1 of the 2-Part Webinar - Obesity and Prostate Cancer Risk: Gaps in Our Current Understanding, and Thoughts on How to Close the Gaps
Date Posted: February 23, 2023

Part 2 of the 2-Part Webinar - Obesity and Prostate Cancer Risk: Gaps in Our Current Understanding, and Thoughts on How to Close the Gaps
Date Posted: February 23, 2023

2023 “Investigators' and Site Coordinators' Opportunity for Research Excellence” (I-SCORE) HYBRID meeting
Date Posted: February 8, 2023

Preventing the Progression of Low-Risk Localized Prostate Cancers: A New Frontier
Date Posted: January 17, 2020